Assay Biology & Screening
Integrated biochemical, cellular, imaging, immunology, and biomarker assays delivering rapid, decision-ready data to accelerate discovery programs.
In Vivo Pharmacology
Validated disease models and translational pharmacology studies integrating efficacy, exposure, biomarkers, and mechanism to enable confident go/no-go decisions
IND-Enabling Studies
Accelerate IND-enabling programs with integrated toxicology, pathology, bioanalysis, toxicokinetic, SEND, and regulatory support through a connected nonclinical development platform.
DMPK Automation Capabilities
Accelerate decision-making with automated ADME-DMPK workflows, high-throughput analytics, and end-to-end support across diverse therapeutic modalities.
Biotransformation, NDSRI & Advanced Modalities
Comprehensive DMPK support spanning biotransformation, nitrosamine safety assessment, metabolite identification, and PK/ADME studies across emerging therapeutic modalities
Transporter Assays
Comprehensive transporter DDI assessment with uptake and efflux assays, supporting regulatory submissions through validated platforms and integrated DMPK expertise
Safety Assessment services
Syngene offers the full range of IND-enabling Exploratory and GLP Tox studies for small molecules and biologics.
Driving operational excellence with SQDECC
SQDECC is an industry-recognized model that enables the operational teams to get a unified view of their efficiency across parameters of Safety, Quality, Delivery, Engagement, Cost, and Compliance (SQDECC).
Achieving Biologics manufacturing milestones using a systemic approach to Technology Transfer
Learn how Syngene achieves manufacturing milestones in Biologics using a systemic approach to 100% ‘first-time right’ technology transfer.
How Organocatalysis discovered by Nobel laureates revolutionised drug development and production in Syngene
David Macmillan and Benjamin List are joint Nobel prize winners for 2021 in chemistry for their ground-breaking work on the development of asymmetric organocatalysis. The efficacy of organocatalysis in asymmetric synthesis has influenced the field of organic synthesis since the early 2000s. Recognising this powerful science, the Discovery Chemistry team at Syngene has transitioned from […]